Home
Search

Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
BIO Statement on Most Favored Nation
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on Most Favored Nation policies:"For too many years, Americans have subsidized the research…
Learn more
BIO Statement on Industry Tariffs
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on the potential for 100% tariffs on branded or patented medicines in the US:“We share the Administration’s…
Learn more
BIO Extends Agreement with Avantor for Five…
Collaboration maximizes BIO members’ access to Avantor’s market-leading portfolio of products, materials, and services to accelerate scientific innovation. WASHINGTON, D.C., September 17, 2025 - The Biotechnology Innovation Organization (BIO)…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
BIO Selects Des Moines as Venue for the 2019 BIO World Congress on Industrial Biotechnology
February 26, 2018
The Biotechnology Innovation Organization (BIO) today announced the selection of Des Moines, Iowa, as the location for the 2019 BIO World Congress on Industrial Biotechnology. The event will be held July 8-11, 2019 and it will host industry…
BIO Statement on President’s Proposed 2019 Budget
February 13, 2018
Washington, D.C. (February 13, 2018) — Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement in response to President Trump’s FY 2019 budget proposal.
BIO Expresses Strong Support for TRID Improvement Act
February 12, 2018
Legislation provides critical regulatory relief to small, pre-revenue emerging companiesWashington, D.C. (February 12, 2018)— The Biotechnology Innovation Organization (BIO) announced its strong support today for H.R. 3978, the TRID Improvement Act…
BIO Releases Report on State of Innovation for Pain and Addiction Therapeutics
February 12, 2018
Report highlights the need to stimulate innovationto battle the opioid epidemicWashington, DC (February 12, 2018) – Today, the Biotechnology Innovation Organization (BIO) released a new report, The State of Innovation in Highly Prevalent…
BIO Applauds Introduction of the Vaccine Access Improvement Act
February 9, 2018
Washington, DC (February 9, 2018) – – The Biotechnology Innovation Organization (BIO) applauds Reps. Mike Kelly (R-PA) and Brian Higgins (D-NY) for introducing H.R. 4993, the Vaccine Access Improvement Act, which would promote timely access to…
South Dakota Governor Daugaard Signs Bill Facilitating Patient Access to Interchangeable Biologic Medicines
February 9, 2018
Washington, D.C. (February 09, 2018) – The Biotechnology Innovation Organization (BIO) and the South Dakota Biotech Association commend Governor Dennis Daugaard for signing critical legislation to create a pathway for the substitution of…
BIO Statement on Medicare Part D Changes in Budget Deal
February 8, 2018
Washington, DC (February 8, 2018) – BIO President and CEO Jim Greenwood issued the following statement today regarding proposed changes to the Medicare Part D program in the announced budget deal.
BIO Statement on U.S. Falling to 12th Ranking of International Patent System Strength
February 8, 2018
The steady decline of America as an innovation-supporting economy is due to an unbalanced patent challenge system.  
BIO’s Statement on the Confirmation of Andrei Iancu to Lead the U.S. Patent and Trademark Office
February 5, 2018
Washington, D.C. (February 5, 2018) – The following statement may be attributed to BIO President & CEO James Greenwood:“I congratulate Andrei Iancu on his Senate confirmation to fill the position of Under Secretary of Commerce for Intellectual…
BIO Applauds USDA-FDA Agreement to Improve Coordination
January 30, 2018
Washington, D.C. (January 30, 2018) – The Biotechnology Innovation Organization (BIO) is applauding a new agreement announced by the U.S. Department of Agriculture (USDA) and the Food and Drug Administration (FDA) to enhance coordination between the…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy. 

Sign Up Today